General Information
Product name
1,7-Dihydro-6H-purine-6-thione monohydrate
Product Synonyms
None
Chemical name
1,7-Dihydro-6H-purine-6-thione monohydrate
CAS No.
6112-76-1
1.2.1 Relevant identified uses
Maintenance therapy of acute lymphatic (lymphocytic , lymophoblastic) leukemia
Manufacturer Name
Boehringer Ingelheim Roxane Inc
Emergency telephone
(614) 276-4000
Icons in SDS
Company Information
company name
Boehringer Ingelheim Roxane Inc
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Emergency Physical State: Round, biconvex, scored tablets Overview The 50 mg tablets are pale yellow with “54 420” engraved on one side and a scored line on the other. Odor: Slight WARNING! May be harmful if swallowed. Accidental ingestion of large amounts may be harmful. Primary Route(s) of Entry Ingestion
Potential health effects
Inhalation: Not expected to be an inhalation hazard in final pharmaceutical form. Eye Contact: Not expected to be a hazard to the eye in final pharmaceutical form. Skin Contact: Not expected to be a hazard to the skin. Can cause hypersensitive reactions resulting in rash, redness, itching and inflammation. Ingestion: May be harmful if ingested. Ingestion may cause nausea, vomiting, diarrhea and adverse bone marrow and renal effects. Toxicity Data: See Section 11 Effects of The potential for exposure is reduced in finished pharmaceutical form. Overexposure: Overexposure by ingestion may cause nausea, vomiting and diarrhea. Delayed effects may include myelosuppression, liver dysfunction, pancreatitis and gastroenteritis. Target Organs: Gastrointestinal Tract